全文获取类型
收费全文 | 7983篇 |
免费 | 370篇 |
国内免费 | 34篇 |
专业分类
耳鼻咽喉 | 46篇 |
儿科学 | 140篇 |
妇产科学 | 66篇 |
基础医学 | 822篇 |
口腔科学 | 139篇 |
临床医学 | 566篇 |
内科学 | 2443篇 |
皮肤病学 | 289篇 |
神经病学 | 531篇 |
特种医学 | 275篇 |
外科学 | 1169篇 |
综合类 | 16篇 |
预防医学 | 220篇 |
眼科学 | 103篇 |
药学 | 351篇 |
中国医学 | 12篇 |
肿瘤学 | 1199篇 |
出版年
2023年 | 40篇 |
2022年 | 79篇 |
2021年 | 161篇 |
2020年 | 108篇 |
2019年 | 131篇 |
2018年 | 160篇 |
2017年 | 149篇 |
2016年 | 155篇 |
2015年 | 146篇 |
2014年 | 196篇 |
2013年 | 241篇 |
2012年 | 440篇 |
2011年 | 432篇 |
2010年 | 270篇 |
2009年 | 227篇 |
2008年 | 369篇 |
2007年 | 432篇 |
2006年 | 403篇 |
2005年 | 433篇 |
2004年 | 420篇 |
2003年 | 392篇 |
2002年 | 439篇 |
2001年 | 204篇 |
2000年 | 175篇 |
1999年 | 182篇 |
1998年 | 110篇 |
1997年 | 86篇 |
1996年 | 68篇 |
1995年 | 54篇 |
1994年 | 57篇 |
1993年 | 60篇 |
1992年 | 140篇 |
1991年 | 122篇 |
1990年 | 132篇 |
1989年 | 143篇 |
1988年 | 103篇 |
1987年 | 103篇 |
1986年 | 108篇 |
1985年 | 107篇 |
1984年 | 84篇 |
1983年 | 79篇 |
1982年 | 36篇 |
1980年 | 32篇 |
1979年 | 50篇 |
1978年 | 37篇 |
1977年 | 28篇 |
1976年 | 25篇 |
1974年 | 38篇 |
1973年 | 26篇 |
1972年 | 27篇 |
排序方式: 共有8387条查询结果,搜索用时 15 毫秒
131.
Teruhiko Imamura Toshihide Izumida Masakazu Hori Shuhei Tanaka Koichiro Kinugawa 《The Journal of international medical research》2022,50(7)
Cardiac amyloidosis usually presents with diastolic dysfunction, but sometimes systolic dysfunction develops, particularly at its advanced stage. However, the therapeutic strategy for patients with cardiac amyloidosis and systolic dysfunction remains unknown. We report a 77-year-old man who was diagnosed with wild-type cardiac amyloidosis and systolic dysfunction with a left ventricular ejection fraction of 27%. Following 6-month medical therapy of tafamidis 80 mg and neurohormonal blockers (carvedilol 5.0 mg, enalapril 2.5 mg, and spironolactone 25 mg), the left ventricular ejection fraction improved to 55%. Tafamidis-incorporated neurohormonal blocker therapy might be a promising strategy to facilitate cardiac reverse remodeling in patients with cardiac amyloidosis and systolic dysfunction. 相似文献
132.
Up-regulation of Akt and eNOS induces vascular smooth muscle cell differentiation in hypertension in vivo 总被引:2,自引:0,他引:2
Kawahara S Umemoto S Tanaka M Umeji K Matsuda S Kubo M Matsuzaki M 《Journal of cardiovascular pharmacology》2005,45(4):367-374
Recent studies have shown that angiotensin II type 1 (AT1) receptor-mediated Akt activation induces vascular smooth muscle cell (VSMC) dedifferentiation in vitro. However, the critical signal transductions affecting the VSMC phenotype remain unclear in vivo. We examined whether signal transduction through AT1 receptor-mediated reactive oxygen species (ROS) could regulate the VSMC phenotype in stroke-prone spontaneously hypertensive rats (SHRSPs). Male SHRSPs were randomized and treated for 6 weeks with a vehicle, an ACE inhibitor cilazapril, or an AT1 receptor antagonist E4177. The 2 drugs showed equipotent effects on the blood pressure, aortic morphology, and collagen deposition. Both drugs also significantly reduced aortic NAD(P)H oxidase activity and p38MAPK and ERK expression, whereas p-Akt, eNOS, and SM2 were significantly increased in SHRSP aortas. Furthermore, E4177 was more effective than cilazapril at inducing VSMC differentiation by reducing NAD(P)H oxidase activity, and up-regulating p-Akt, eNOS, and SM2. Thus, an ACE inhibitor and an AT1 receptor antagonist inhibited VSMC dedifferentiation through inhibition of NAD(P)H oxidase activity and up-regulation of eNOS and Akt in SHRSP aortas, suggesting that in contrast to the in vitro experiments, AT1 receptor-mediated NAD(P)H oxidase-generated ROS, eNOS, and Akt might be crucial determinants for the VSMC phenotype in hypertension in vivo. 相似文献
133.
Ryota Imai Masakazu Imaoka Hidetoshi Nakao Mitsumasa Hida Fumie Tazaki Takao Inoue Junya Orui Misa Nakamura 《Medicine》2022,101(32)
Older people with chronic pain are at higher risk of developing sarcopenia. Central sensitization (CS) has been implicated in chronic pain among community-dwelling older adults. However, a relationship between CS and chronic pain with sarcopenia has not been established. This cross-sectional study aimed to clarify the relationship between chronic pain with sarcopenia or presarcopenia and CS among community-dwelling older adults. We assessed chronic pain and sarcopenia in 104 older adults participating in community health checks. We defined sarcopenia using the Asian Working Group for Sarcopenia (AWGS) consensus recommendations based on the following outcomes: low muscle mass, low muscle strength, and slow gait speed. Pain-related assessments included pain intensity, the Pain Catastrophizing Scale, the CS Inventory-9, the pressure pain threshold, the Tampa Scale of Kinesiophobia-11, and the EuroQol 5-dimension 5-level (EQ5D-5L). Chronic pain was defined by related symptoms within the month prior to the health check that had continued for ≥ 3 months and corresponded to a numerical rating scale score of ≥ 1 at the site of maximum pain. The prevalence of chronic pain was 43.3%. In addition, the prevalence of chronic pain with sarcopenia or presarcopenia was 29.8%. A logistic regression analysis revealed that the pressure pain threshold (odds ratio: 0.82, 95% CI: 0.95–1.02) and the EQ5D-5L (odds ratio: 0.58, 95% CI: 0.36–0.76) were significantly associated with the presence of chronic pain with sarcopenia or presarcopenia. Chronic pain with sarcopenia or presarcopenia was affected by central sensitization. Therefore, CS should be evaluated in the elderly. 相似文献
134.
Akito Nishimura Masayuki Tateiwa Shuuitirou Tajima Takuya Tada 《Journal of Rural Medicine》2022,17(3):193
Objective: Treatment options for patients with rheumatoid arthritis on maintenance hemodialysis with an inadequate response to biologic agents have not been reported. In this report, we describe two patients who achieved remission after treatment with peficitinib.Methods: Two 69- and 85-year-old patients with rheumatoid arthritis on maintenance hemodialysis were previously treated with biologics and started on peficitinib 100 mg/day after the secondary failure of biologics.Discussion: In the two cases presented here, rheumatoid arthritis was almost in remission and there were no adverse events, although the patients were switched to peficitinib after secondary failure of the biologic agents. Among Janus kinase inhibitors, peficitinib has the lowest renal excretion; therefore, its administration in patients on dialysis is not contraindicated according to the package insert in Japan. The use of biologic agents in patients on hemodialysis has been reported to be associated with a high incidence of infections; therefore, care should be taken to avoid infections when administering Janus kinase inhibitors.Conclusion: Janus kinase inhibitors with low renal excretion, such as peficitinib, may be effective in patients with rheumatoid arthritis on maintenance hemodialysis who have an inadequate response to biologic agents. 相似文献
135.
136.
137.
Kazumichi Kawakubo Hiroyuki Isayama Yousuke Nakai Naoki Sasahira Hirofumi Kogure Takashi Sasaki Kenji Hirano Minoru Tada Kazuhiko Koike 《Gut and liver》2012,6(3):399-402
Patients with pancreatic cancer frequently suffer from both biliary and duodenal obstruction. For such patients, both biliary and duodenal self-expandable metal stent placement is necessary to palliate their symptoms, but it was difficult to cross two metal stents. Recently, endoscopic ultrasonography-guided choledochoduodenostomy (EUS-CDS) was reported to be effective for patients with an inaccessible papilla. We report two cases of pancreatic cancer with both biliary and duodenal obstructions treated successfully with simultaneous duodenal metal stent placement and EUS-CDS. The first case was a 74-year-old man with pancreatic cancer. Duodenoscopy revealed that papilla had been invaded with tumor and duodenography showed severe stenosis in the horizontal portion. After a duodenal uncovered metal stent was placed across the duodenal stricture, EUS-CDS was performed. The second case was a 63-year-old man who previously had a covered metal stent placed for malignant biliary obstruction. After removing the previously placed metal stent, EUS-CDS was performed. Then, a duodenal covered metal stent was placed across the duodenal stenosis. Both patients could tolerate a regular diet and did not suffer from stent occlusion. EUS-CDS combined with duodenal metal stent placement may be an ideal treatment strategy in patients with pancreatic cancer with both duodenal and biliary malignant obstruction. 相似文献
138.
Nogawa T Takahashi S Okano A Kawatani M Uramoto M Saito T Osada H 《The Journal of antibiotics》2012,65(3):123-128
Two new 6,6-spiroacetal polyketides, spirotoamides A (1) and B (2), were isolated from a microbial metabolite fraction library of Streptomyces griseochromogenes JC82-1223 by screening of structurally unique compounds based on a search of spectral database. The fraction library was constructed using a systematic separation method to efficiently discover new metabolites from microbial sources such as actinomycetes and fungi. The structures of 1 and 2 were elucidated by 2D-NMR and mass spectrometric measurements. They belong to a class of polyketides, and contain a 6,6-spiroacetal core structure and a carboxamide group. The biosynthetic pathway of 1 and 2 is discussed in the text. 相似文献
139.
Endoscopic features and genetic background of inflammatory bowel disease complicated with Takayasu arteritis 下载免费PDF全文
140.